Sobre 4 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the complete record of transactions filed by Legorreta Pablo G., Consejero. Officer active across 3 companies, notably Royalty Pharma plc. In total, 20 reports have been recorded. Breakdown: 6 buys · 0 sell. Total volume traded: €95.8m. Activity tracked since 7 May 2021. The latest transaction was disclosed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Legorreta Pablo G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1.040.410 títulos0Class A Ordinary SharesSEC:0000950103-21-007075:0
20 de 20 declaraciones
About Legorreta Pablo G.
Legorreta Pablo G. is Chief Executive Officer, Chairman and Director. He has filed 19 filings in total, and across the 19 sampled recent filings the recorded transactions are purchases for EUR 95802560 and no sales, between 2021-05-11 and 2026-02-13. The largest recent filings concern Prokidney CORP., Epizyme, Inc. and Royalty Pharma plc.